Your browser doesn't support javascript.
loading
Strategies for the development of metalloimmunotherapies.
Sun, Xiaoqi; Zhou, Xingwu; Shi, Xiaoyue; Abed, Omar A; An, Xinran; Lei, Yu Leo; Moon, James J.
Afiliação
  • Sun X; Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, USA. sunxqi@umich.edu.
  • Zhou X; Biointerfaces Institute, University of Michigan, Ann Arbor, MI, USA. sunxqi@umich.edu.
  • Shi X; Editas Medicine, Cambridge, MA, USA. sunxqi@umich.edu.
  • Abed OA; Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, USA.
  • An X; Biointerfaces Institute, University of Michigan, Ann Arbor, MI, USA.
  • Lei YL; Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, USA.
  • Moon JJ; Biointerfaces Institute, University of Michigan, Ann Arbor, MI, USA.
Nat Biomed Eng ; 2024 Jun 24.
Article em En | MEDLINE | ID: mdl-38914800
ABSTRACT
Metal ions play crucial roles in the regulation of immune pathways. In fact, metallodrugs have a long record of accomplishment as effective treatments for a wide range of diseases. Here we argue that the modulation of interactions of metal ions with molecules and cells involved in the immune system forms the basis of a new class of immunotherapies. By examining how metal ions modulate the innate and adaptive immune systems, as well as host-microbiota interactions, we discuss strategies for the development of such metalloimmunotherapies for the treatment of cancer and other immune-related diseases.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article